Receptor-ligand binding

Concept

Receptor-ligand binding

T-038Home BU-202Threads regulation · information

Statement

Specificity and affinity in molecular recognition.

Why it matters

Nearly every mechanism of cellular communication in this unit begins with the same physical event: a signalling molecule (ligand) binding a specific receptor protein with measurable affinity and specificity. signal-transduction presupposes that this binding step has already occurred and asks what happens next inside the cell; second-messengers presupposes the same; and resting-membrane-potential's Nernst-equation treatment of ion gradients is a parallel example of equilibrium thinking applied to a different biophysical quantity. Quantifying binding — not just describing it qualitatively as "specific" — is what makes concepts like drug potency, hormone sensitivity, and receptor saturation precise, comparable, and predictive rather than descriptive.

The framework developed here is also the direct biophysical foundation receptor-pharmacology builds on: agonism, antagonism, and dose-response curves are all pharmacological refinements of the same equilibrium binding law derived below.

Hypotheses

Receptor and ligand bind reversibly in a single bimolecular equilibrium step, governed by the law of mass action.This excludes cooperative binding among multiple sites (treated separately, as in oxygen-dissociation-curve's sigmoidal haemoglobin-oxygen curve) and excludes irreversible covalent binding; the simple hyperbolic saturation curve derived below applies specifically to the single-site, reversible case. Total receptor concentration is small enough, or ligand concentration large enough, that the free ligand concentration is not significantly depleted by binding.Without this "ligand not depleted" condition, the free ligand concentration \([L]\) appearing in the equilibrium expression would itself depend on how much ligand is already bound, complicating the simple algebraic solution below into a quadratic form; the approximation is generally excellent whenever ligand is present in large excess over receptor, as is typical for hormone or neurotransmitter binding to cell-surface receptors.

Proof

R + L \rightleftharpoons RL

A receptor \(R\) and ligand \(L\) associate reversibly to form the bound complex \(RL\); at equilibrium, the forward (association) and reverse (dissociation) rates are equal, so the net concentration of each species is no longer changing. A

K_d = \frac{[R][L]}{[RL]}

Applying the law of mass action to the equilibrium of Step 1 defines the equilibrium dissociation constant \(K_d\), with units of concentration; a smaller \(K_d\) corresponds to tighter (higher-affinity) binding, since it means equilibrium favours the bound complex \(RL\) even at low free ligand concentration. A

[R]_{\text{total}} = [R] + [RL]

Total receptor is conserved between its free (\(R\)) and ligand-bound (\(RL\)) forms; this conservation law, combined with the equilibrium expression of Step 2, allows both unknown concentrations to be solved for in terms of \([R]_{\text{total}}\), \([L]\), and \(K_d\) alone. A

\theta \equiv \frac{[RL]}{[R]_{\text{total}}} = \frac{[L]}{K_d + [L]}

Substituting Step 3 into Step 2 and rearranging gives fractional receptor occupancy \(\theta\) (the proportion of total receptor that is ligand-bound) as a function of free ligand concentration alone; this is a rectangular hyperbola in \([L]\), rising from \(0\) at \([L]=0\) and approaching \(1\) (full saturation) as \([L]\to\infty\), never exceeding it. A

\theta = \tfrac12 \iff [L] = K_d

Setting \(\theta=1/2\) in Step 4 and solving gives \([L]=K_d\) directly: the dissociation constant has the direct physical meaning of the free ligand concentration at which exactly half the receptor population is occupied, giving \(K_d\) an operational definition that can be read straight off a measured binding curve. A

Result

\theta = \frac{[L]}{K_d+[L]}, \qquad K_d = \frac{[R][L]}{[RL]}

Reading. Receptor occupancy rises hyperbolically, not linearly, with ligand concentration, saturating toward complete occupancy at high \([L]\); a single number, \(K_d\), the ligand concentration giving half-maximal occupancy, fully characterises the affinity of a given receptor-ligand pair under this model.

Scope. Applies to simple, single-site, reversible, non-cooperative binding under conditions of negligible ligand depletion (Hypotheses); cooperative multi-site binding (oxygen-dissociation-curve) instead gives a sigmoidal, not hyperbolic, occupancy curve, and departs from this Result's simple algebraic form.

Corollaries & converses

receptor-pharmacology builds directly on this equilibrium binding law: an agonist's potency in a functional assay is closely related to (though not always numerically identical to) its \(K_d\) for the receptor, and pharmacological antagonism is most naturally understood as one ligand's occupancy competing against another's within exactly this framework.
signal-transduction and second-messengers both take receptor occupancy \(\theta\) as their starting input: the downstream cellular response is generically a function of how many receptors are currently ligand-bound, which is precisely the quantity this Result computes.
Converse: given a measured saturation-binding curve (occupancy versus free ligand concentration), \(K_d\) can be read directly off the curve as the ligand concentration at half-maximal occupancy (Step 5), without needing to measure \([R]\) or \([RL]\) separately at every point.

Fails without

Drop the single-site, non-cooperative assumption (Hypotheses): if binding of one ligand molecule changes the receptor's affinity for a second (as in haemoglobin's four-subunit cooperative binding, oxygen-dissociation-curve), occupancy no longer follows the simple hyperbolic form of Step 4 at all — it instead follows a sigmoidal curve, and a single \(K_d\) is no longer sufficient to describe the system, since apparent affinity itself now changes with ligand concentration.
Drop the "ligand not depleted" assumption when receptor concentration is comparable to or exceeds ligand concentration: free ligand concentration \([L]\) can then differ substantially from total ligand added, since a significant fraction becomes bound; using total (rather than free) ligand concentration in Step 4's formula in this regime systematically overestimates occupancy at a given nominal ligand dose and \(K_d\) estimated this way will be inaccurate.

Common errors

Confusing \(K_d\) with the total ligand concentration needed to detect any binding at all; \(K_d\) specifically marks half-maximal occupancy (Step 5), and measurable, functionally significant binding already occurs at ligand concentrations well below \(K_d\) (Step 4's hyperbola is nonzero for any \([L]>0\)).
Assuming a lower \(K_d\) means weaker binding; \(K_d\) is a dissociation constant, so a smaller \(K_d\) corresponds to a smaller free-ligand-times-free-receptor product relative to bound complex at equilibrium, i.e. tighter, higher-affinity binding, not weaker binding (Step 2).
Assuming occupancy \(\theta\) rises linearly with ligand concentration rather than following the saturating hyperbola of Step 4; this leads to systematic overestimation of the response expected at high ligand concentrations, where the curve is already flattening toward its maximum.
Treating affinity (\(K_d\), a purely binding property) as interchangeable with efficacy (the magnitude of the functional response once bound, receptor-pharmacology) — two ligands can have identical \(K_d\) values yet produce very different downstream responses once bound.

Discussion

The mass-action treatment of receptor binding is a direct biological application of the same law of mass action Guldberg and Waage formulated for chemical equilibria in the 1860s; applying it to a single receptor-ligand pair, rather than a bulk chemical reaction, became standard practice in pharmacology through the twentieth century as radioligand binding assays made direct, quantitative measurement of \(K_d\) values routine.

Real binding data is very often analysed by linearising Step 4's hyperbola — the Scatchard transformation, plotting \([RL]/[L]\) against \([RL]\), turns the hyperbolic saturation curve into a straight line whose slope is \(-1/K_d\) and whose intercepts give \(K_d\) and receptor number directly; a curved (rather than straight) Scatchard plot is itself a standard diagnostic that the single-site, non-cooperative assumption of the Hypotheses has broken down, for example due to two distinct receptor populations with different affinities, or genuine cooperativity.

Common misconception: that specificity (a receptor binding one ligand and essentially no others) and affinity (how tightly a receptor binds the ligand it does recognise, quantified by \(K_d\)) are the same property. A receptor can bind one ligand with very high specificity yet only moderate affinity, or bind several related ligands (low specificity) with high affinity for each; the two are independent axes describing different aspects of the recognition event.

Worked examples

\text{A receptor has } K_d = 10\,\text{nM}. \text{ Find fractional occupancy at } [L]=10\,\text{nM and at } [L]=90\,\text{nM}.

Using Step 4, \(\theta=[L]/(K_d+[L])\). At \([L]=10\,\text{nM}=K_d\): \(\theta=10/(10+10)=0.5\), exactly matching Step 5's prediction that occupancy is half-maximal when \([L]=K_d\). At \([L]=90\,\text{nM}\): \(\theta=90/(10+90)=0.9\). A

\theta(10\,\text{nM})=0.50, \qquad \theta(90\,\text{nM})=0.90

Reading. A ninefold increase in ligand concentration only raises occupancy from \(50\%\) to \(90\%\), not proportionally — direct illustration of the saturating, sub-linear shape of the binding curve near and above \(K_d\).

Scope. The same substitution into Step 4 gives occupancy at any ligand concentration once \(K_d\) is known, for any single-site, non-cooperative receptor-ligand pair.

Problems

A receptor has \(K_d=50\,\text{nM}\). Find the free ligand concentration required to achieve \(75\%\) receptor occupancy.
Solution
From Step 4, \(0.75=[L]/(50+[L])\). Rearranging: \(0.75(50+[L])=[L]\), so \(37.5+0.75[L]=[L]\), giving \(0.25[L]=37.5\) and \([L]=150\,\text{nM}\).
Two receptors, A and B, are compared at the same free ligand concentration \([L]=20\,\text{nM}\). Receptor A has \(K_d=5\,\text{nM}\) and receptor B has \(K_d=100\,\text{nM}\). Which receptor shows higher occupancy at this ligand concentration, and what does this imply about their relative affinities?
Solution
Receptor A: \(\theta_A=20/(5+20)=0.80\). Receptor B: \(\theta_B=20/(100+20)=0.167\). Receptor A shows much higher occupancy at the same ligand concentration. Since A's \(K_d\) is smaller, A has the higher affinity for this ligand (Step 2 and Common errors' second bullet), consistent with A reaching much greater occupancy at an identical ligand concentration.
A researcher measures binding at ligand concentrations comparable to receptor concentration, and finds that a Scatchard plot of the data is markedly curved rather than a straight line. Using the Hypotheses and Discussion, propose two distinct possible explanations.
Solution
A curved Scatchard plot indicates the single-site, non-cooperative model of the Hypotheses does not hold exactly. Two standard explanations: (1) the receptor preparation actually contains two distinct populations of binding sites with different \(K_d\) values, so the data reflects a mixture of two hyperbolas rather than one; (2) the receptor shows genuine positive or negative cooperativity between binding sites (as in oxygen-dissociation-curve's haemoglobin), violating the single-site assumption directly and requiring a more elaborate model than Step 4's simple hyperbola.